IO Biotech Company

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Last Funding Date: 2021-10-07
Investors Number: 16
Industry: Peptides and Proteins
Last Funding Type: Series C
Headquarters: Copenhagen, Hovedstaden, Denmark
Total Funding: 175012360
Funding Status: IPO
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Founded Date: 2014-12-23